COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 118 filers reported holding COHERUS BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182 | -60.4% | 48,893 | -54.7% | 0.00% | – |
| Q2 2023 | $460 | +411.1% | 107,836 | +712.3% | 0.00% | – |
| Q1 2023 | $90 | -69.6% | 13,275 | -64.5% | 0.00% | – |
| Q4 2022 | $296 | -99.9% | 37,415 | +24.8% | 0.00% | – |
| Q3 2022 | $288,000 | -67.9% | 29,977 | -75.8% | 0.00% | -100.0% |
| Q2 2022 | $898,000 | +6314.3% | 124,118 | +10816.3% | 0.00% | – |
| Q1 2022 | $14,000 | -60.0% | 1,137 | -48.9% | 0.00% | – |
| Q4 2021 | $35,000 | +94.4% | 2,223 | +72.6% | 0.00% | – |
| Q3 2021 | $18,000 | -35.7% | 1,288 | -38.3% | 0.00% | – |
| Q2 2021 | $28,000 | – | 2,088 | -76.2% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 8,768 | +161.2% | 0.00% | – |
| Q4 2020 | $58,000 | +2800.0% | 3,357 | +2564.3% | 0.00% | – |
| Q3 2020 | $2,000 | -91.7% | 126 | -90.7% | 0.00% | – |
| Q2 2020 | $24,000 | +9.1% | 1,355 | -4.0% | 0.00% | – |
| Q1 2020 | $22,000 | -76.1% | 1,412 | -72.5% | 0.00% | – |
| Q4 2019 | $92,000 | -73.1% | 5,138 | -69.6% | 0.00% | -100.0% |
| Q3 2019 | $342,000 | -66.7% | 16,886 | -63.7% | 0.00% | -66.7% |
| Q2 2019 | $1,028,000 | +1803.7% | 46,556 | +1074.8% | 0.00% | – |
| Q1 2019 | $54,000 | +45.9% | 3,963 | -4.0% | 0.00% | – |
| Q4 2018 | $37,000 | -68.4% | 4,127 | -41.9% | 0.00% | – |
| Q3 2018 | $117,000 | -38.1% | 7,098 | -47.4% | 0.00% | -100.0% |
| Q2 2018 | $189,000 | +24.3% | 13,501 | -2.4% | 0.00% | -85.7% |
| Q1 2018 | $152,000 | -30.6% | 13,833 | -44.6% | 0.01% | -22.2% |
| Q4 2017 | $219,000 | +62.2% | 24,973 | +146.0% | 0.01% | +50.0% |
| Q3 2017 | $135,000 | -13.5% | 10,152 | +36.9% | 0.01% | -14.3% |
| Q1 2017 | $156,000 | +457.1% | 7,417 | +590.0% | 0.01% | +250.0% |
| Q3 2016 | $28,000 | +250.0% | 1,075 | +115.4% | 0.00% | +100.0% |
| Q2 2016 | $8,000 | +300.0% | 499 | +292.9% | 0.00% | – |
| Q1 2016 | $2,000 | -94.7% | 127 | -92.4% | 0.00% | -100.0% |
| Q4 2015 | $38,000 | +1800.0% | 1,675 | +1436.7% | 0.00% | – |
| Q3 2015 | $2,000 | – | 109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |